Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Carcinoma of the Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03324282
What this trial is testing

First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma

Who this might be right for
Bladder Carcinoma
University Hospital, Bordeaux 65
Not applicableNot Yet RecruitingNCT07203989
What this trial is testing

The Effect of Video Calls With Family Members During Operating Room Waiting on Stress, Anxiety, and Surgical Fear in Patients Undergoing Transurethral Resection of Bladder Tumor

Who this might be right for
Bladder Tumor (TURBT)Bladder (Urothelial, Transitional Cell) Cancer
Bitlis Eren University 124
Testing effectiveness (Phase 2)WithdrawnNCT02718742
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy and Surgery in Treating Patients With High-Risk Bladder Cancer

Who this might be right for
Recurrent Bladder Urothelial CarcinomaStage IV Bladder Urothelial Carcinoma
Mayo Clinic
Testing effectiveness (Phase 2)Ended earlyNCT00995488
What this trial is testing

Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer

Who this might be right for
Urothelial CancerBladder Cancer
University of Michigan Rogel Cancer Center 16
Not applicableActive Not RecruitingNCT00902590
What this trial is testing

A Genotype-Phenotype Urothelial Cancer Registry

Who this might be right for
Urothelial CancerRenal Pelvis CancerUreter Cancer+1 more
Memorial Sloan Kettering Cancer Center 3,519
Testing effectiveness (Phase 2)UnknownNCT05401279
What this trial is testing

Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer

Who this might be right for
Urothelial Carcinoma BladderPD-1 Inhibitor
RenJi Hospital 20
Early research (Phase 1)Active Not RecruitingNCT05483868
What this trial is testing

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder CancerNMIBCNon-Muscle Invasive Bladder Carcinoma+3 more
Aura Biosciences 55
Large-scale testing (Phase 3)Study completedNCT00406068
What this trial is testing

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Neoplasms
Bioniche Life Sciences Inc. 129
Large-scale testing (Phase 3)Active Not RecruitingNCT03682068
What this trial is testing

Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer

Who this might be right for
Unresectable Locally Advanced Urothelial CancerMetastatic Urothelial Cancer
AstraZeneca 1,246
Early research (Phase 1)Study completedNCT03236935
What this trial is testing

Phase Ib of L-NMMA and Pembrolizumab

Who this might be right for
Non-Small Cell Lung CancerMalignant MelanomaHead and Neck Squamous Cell Carcinoma+3 more
The Methodist Hospital Research Institute 12
Testing effectiveness (Phase 2)Looking for participantsNCT06571708
What this trial is testing

Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)

Who this might be right for
Bladder CancerMuscle-Invasive Bladder Carcinoma
Columbia University 36
Early research (Phase 1)Study completedNCT04200963
What this trial is testing

A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaUrothelial Carcinoma BladderBladder Cancer+18 more
Ikena Oncology 78
Not applicableAvailableNCT06443944
What this trial is testing

An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG

Who this might be right for
Non-Muscle Invasive Bladder CancerUrothelial CarcinomaUrologic Cancer+1 more
CG Oncology, Inc.
Very early researchEnded earlyNCT03266900
What this trial is testing

A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival

Who this might be right for
Bladder CancerBladder Urothelial Carcinoma
University Health Network, Toronto 2
Large-scale testing (Phase 3)Study completedNCT05136898
What this trial is testing

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder
UroGen Pharma Ltd. 8
Testing effectiveness (Phase 2)UnknownNCT03030157
What this trial is testing

Single Versus Long-term Intravesical Instillation Chemotherapy for Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma

Who this might be right for
Intravesical Instillation
RenJi Hospital 220
Large-scale testing (Phase 3)Looking for participantsNCT07067749
What this trial is testing

Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerBladder Cancer Requiring CystectomyBladder Carcinoma+2 more
University of Rome Tor Vergata 92
Not applicableStudy completedNCT07043790
What this trial is testing

Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma

Who this might be right for
Transitional Cell Bladder CancerCystectomyRadiation
Ain Shams University 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT04216290
What this trial is testing

Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

Who this might be right for
Bladder Urothelial CarcinomaStage III Bladder Cancer AJCC v8
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Study completedNCT00407485
What this trial is testing

VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium

Who this might be right for
Adenocarcinoma of the BladderDistal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+10 more
National Cancer Institute (NCI) 22
Next Page